106 results on '"Bruzek, Amy"'
Search Results
2. Complications of the Occult Spinal Dysraphisms
3. BIOM-58. ZERO-WASTE MOLECULAR DIAGNOSTICS FROM BIOPSY NEEDLE WASHES
4. Everolimus improves the efficacy of dasatinib in PDGFR[alpha]-driven glioma
5. Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma
6. Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma
7. Medulloblastoma
8. Middle Fossa Arachnoid Cyst
9. Supplementary Table S3A and S3B from Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma
10. Supplementary Data from Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma
11. CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response
12. Robot-Assisted Minimally Invasive Sacroiliac Joint Fusion for Sacroiliac Joint Dysfunction: 2-Dimensional Operative Video
13. Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma
14. CHFR and Paclitaxel Sensitivity of Ovarian Cancer
15. BIOM-28. SERIAL PLASMA AND CSF CELL-FREE TUMOR DNA (cf-tDNA) TRACKING IN DIFFUSE MIDLINE GLIOMA PATIENTS UNDERGOING TREATMENT WITH ONC201
16. A promising approach for treatment of tumor-induced bone diseases: Utilizing bisphosphonate derivatives of nucleoside antimetabolites
17. Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response
18. EPCT-03. SERIAL PLASMA AND CSF CELL-FREE TUMOR DNA (CF-TDNA) TRACKING IN DIFFUSE MIDLINE GLIOMA PATIENTS UNDERGOING TREATMENT WITH ONC201
19. Serial plasma and CSF cell-free tumor DNA (cf-tDNA) tracking in diffuse midline glioma patients undergoing treatment with ONC201.
20. Everolimus improves the efficacy of dasatinib in the treatment of PDGFRA-driven glioma
21. DIPG-08. ELECTRONIC SEQUENCING PROVIDES OPTIMIZED QUANTIFICATION OF SERIAL, MULTI-GENE MOLECULAR RESPONSE IN THE CSF OF CHILDREN WITH HIGH-GRADE GLIOMA
22. Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma
23. HGG-18. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA
24. CTNI-17. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA
25. Clinical efficacy and predictive biomarkers of ONC201 in H3 K27M-mutant diffuse midline glioma
26. Posterior Cranial Vault Distraction Osteogenesis: Routine Low Occipital Craniotomy Is a Safe Approach That Optimizes Outcomes
27. Syringomyelia in children with closed spinal dysraphism: long-term outcomes after surgical intervention
28. Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma
29. PDCT-12. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA
30. PDTM-10. USE OF A NOVEL, HAND-HELD, ELECTRONIC DNA ANALYSIS PLATFORM TO QUANTIFY MULTI-GENE MOLECULAR RESPONSE IN CSF OF PATIENTS WITH HIGH-GRADE GLIOMA
31. Morphometric changes at the craniocervical junction during childhood
32. The effect of everolimus on CNS penetration and efficacy of dasatinib in the treatment of PDGFRA-driven glioma.
33. DIPG-06. RAPID, ULTRA-DEEP SEQUENCING OF PEDIATRIC DIPG FROM CEREBROSPINAL FLUID USING A NOVEL HAND-HELD ELECTRONIC DNA ANALYSIS PLATFORM
34. HGG-04. USE OF AN ADVANCED RNA-SEQ FUSION PIPELINE RESULTS IN THE TARGETED TREATMENT AND SUSTAINED CLINICAL RESPONSE OF CHILDREN WITH RECURRENT PEDIATRIC HIGH-GRADE GLIOMA
35. HGG-03. EVEROLIMUS TREATMENT IMPROVES THE CNS PENETRATION AND EFFICACY OF DASATINIB IN THE TREATMENT OF PDGFRA-DRIVEN PEDIATRIC HIGH-GRADE GLIOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA
36. Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations
37. PDTM-29. CSF H3F3A K27M CIRCULATING TUMOR DNA COPY NUMBER QUANTIFIES TUMOR GROWTH AND TREATMENT RESPONSE
38. The Preventable Shunt Revision Rate: A Multicenter Evaluation
39. Molecular characterization reveals NF1 deletions and FGFR1‐activating mutations in a pediatric spinal oligodendroglioma
40. MPTH-21. MOLECULAR CHARACTERIZATION REVEALS NF1 LOSS AND FGFR1 ACTIVATING MUTATIONS IN PEDIATRIC SPINAL OLIGODENDROGLIOMA
41. Intramedullary and Extramedullary Cervical Neurenteric Cyst Requiring Fixation and Fusion
42. Preventable Shunt Revision Rate: A Multicenter Evaluation.
43. The Preventable Shunt Revision Rate: A Multicenter Evaluation
44. Pilocytic Astrocytoma Presenting as an Orbital Encephalocele: A Case Report
45. Molecular characterization reveals NF1 deletions and FGFR1-activating mutations in a pediatric spinal oligodendroglioma.
46. Extracorporeal Membrane Oxygenation Support as a Life-saving Measure for Acute Respiratory Distress Syndrome After Craniectomy
47. Control of Centrin Stability by Aurora A
48. Aurora A and B Overexpression and Centrosome Amplification in Early Estrogen-Induced Tumor Foci in the Syrian Hamster Kidney: Implications for Chromosomal Instability, Aneuploidy, and Neoplasia
49. Additional file 2: of CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response
50. Additional file 1: of CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.